Navigation Links
WuXi PharmaTech Announces Second Quarter 2007 Results
Date:9/5/2007

(Unaudited)

Three Months Ended Six Months Ended

June 30, June 30,

2007 2006 2007 2006

Net revenues:

Laboratory services 25,118 12,429 46,794 21,294

Research manufacturing 5,124 2,743 17,267 6,650

Total net revenues 30,242 15,172 64,061 27,944

Cost of revenues (14,968) (8,166) (33,116) (15,505)

Gross profit 15,274 7,006 30,945 12,439

Operating expenses (7,770) (5,488) (17,598) (9,427)

Operating income 7,504 1,518 13,347 3,012

Other income (expenses), net (105) (276) 106 (655)

Income before income taxes 7,399 1,242 13,453 2,357

Income taxes (251) (14) (329) (302)

Net income 7,148 1,228 13,124 2,055

Income (loss) attributable to

holders of ADS (Note 2):

Basic 3,244 (42,110) 2,656 (41,283)

Diluted 3,244 (42,110) 2,656 (41,283)

Basic earnings (loss) per

ADS (Note 2) 0.14 (1.35) 0.11 (1.33)

Diluted earnings (loss) per

ADS (Note 2) 0.11 (1.35) 0.09 (1.33)

Weighted average ADS

outstanding - basic

(Note 2) 22,487,681 31,132,500 23,873,225 31,132,500

Weighted average ADS

outstanding - diluted

(Note 2) 29,324,338 31,132,500 30,452,998 31,132,500

Note 2: One (1) ADS is equal to eight (8) ordinary shares

WUXI PHARMAT
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... , Dec. 23, 2014 Sigma-Aldrich Corporation ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements ... expired on December 22, 2014, thereby completing the ... for the acquisition of the Company by Merck ... clearance satisfies another condition to closing the transaction, ...
(Date:12/22/2014)... Dec. 22, 2014   Synthetic Biologics, ... of pathogen-specific therapies for serious infections and ... microbiome, today announced positive topline safety and ... trial of SYN-004, the Company,s investigational oral ... Clostridium difficile (C. difficile) infection, antibiotic-associated ...
(Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
(Date:12/19/2014)... Hershey, PA (PRWEB) December 19, 2014 ... a leading developer and manufacturer of needle-free injection ... an agreement with Immunomic Therapeutics, Inc. (“ITI”) for ... injection device with its LAMP™ vaccine platform. ... for an exclusive Worldwide license to the Biojector®-2000 ...
Breaking Biology Technology:Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 2Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives U.S. Antitrust Clearance 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 2Bioject and Immunomic Therapeutics Enter into an Agreement for License of Needle-Free Technology for LAMP-vax Vaccines 3
... the hormonal messengers responsible for most of the biological effects ... type responses. T lymphocytes are a major source of cytokines. ... allow recognition of foreign pathogens. There are two main subsets ... molecules known as CD4 and CD8. T lymphocytes expressing CD4 ...
... Michael Leist Varian , ... E-mail: icpms@varianinc.com , Introduction ... and bioavailability can differ greatly between the various chemical species in ... be misleading. Arsenic is one such example where the various species ...
... Z. Yang, Varian, Inc. , ... Nitrofuran antibiotics are veterinary drugs. The use of ... Australia, Canada, Japan, Singapore, Bangladesh, and the European Union because of ... Trace amounts of nitrofurans contamination has been found ...
Cached Biology Technology:Th1 and Th2 Balance, Regulation, and Involvement in Disease 2Speciation of Arsenic by LC-ICP-MS 2Speciation of Arsenic by LC-ICP-MS 3Speciation of Arsenic by LC-ICP-MS 4Speciation of Arsenic by LC-ICP-MS 5Analysis of Nitrofurans Metabolites by Positive Ion Electrospray LC/MS/MS 2
(Date:12/19/2014)... 2014   LaunchKey , the first decentralized mobile ... Internet of Things era, today announced the close of ... was led by Metamorphic Ventures with participation from ENIAC ... and others.  LaunchKey has raised $4 million to date, ... team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... 15, 2014  HITLAB SM announced today ... audit to confirm its adherence to current U.S. ... enables HITLAB to conduct regulated smart device and ... for patient safety and research quality. ... quality, and delivery with innovative technology," said ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally ... more evident than at international borders. Over the ... scanners have allowed veteran travelers to self process ... Control (APC) Kiosks at an increasing number of ... According to Maxine Most ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2
... researchers have discovered Salmonella bacteria that are up ... may help prevent food poisoning outbreaks that continue to plague ... can override vaccines and pose a risk to food safety ... strategies to find the more dangerous bugs were unsuccessful since ...
... CA April 18, 2012 Scientists at The Scripps ... mice from an otherwise lethal overdose of cocaine. The findings ... to reverse the effects of cocaine in case of emergency. ... about 5,000 overdose deaths each year in the United States. ...
... Maastricht, 17 April 2012 The Second European ... Netherlands, brings together high-level researchers, policymakers and practitioners to ... sectors of energy will share their ideas on how ... of environmental and climate impact and also in terms ...
Cached Biology News:UCSB researchers discover particularly dangerous Salmonella 2Scripps Research Institute scientists develop antidote for cocaine overdose 2Scripps Research Institute scientists develop antidote for cocaine overdose 3